Historical Stock Price
CFRXZ historical stock prices picture
CFRXZ (CFRXZ) has the following price history information. Looking back at CFRXZ historical stock prices for the last five trading days, on October 23, 2015, CFRXZ opened at $0.04, traded as high as $0.07 and as low as $0.03, and closed at $0.07. Trading volume was a total of 616.70K shares. On October 26, 2015, CFRXZ opened at $0.08, traded as high as $0.09 and as low as $0.04, and closed at $0.08. Trading volume was a total of 401.40K shares. On October 27, 2015, CFRXZ opened at $0.08, traded as high as $0.08 and as low as $0.05, and closed at $0.05. Trading volume was a total of 702.20K shares. On October 28, 2015, CFRXZ opened at $0.05, traded as high as $0.06 and as low as $0.02, and closed at $0.03. Trading volume was a total of 916.40K shares. On October 29, 2015, CFRXZ opened at $0.03, traded as high as $0.03 and as low as $0.03, and closed at $0.03. Trading volume was a total of 0 shares.

CFRXZ Historical Stock Prices By Date:

CFRXZ historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into CFRXZ shares, starting with a $10,000 purchase of CFRXZ, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 11/20/2014
End date: 10/29/2015
Start price/share: $0.19
End price/share: $0.03
Dividends collected/share: $0.00
Total return: -86.84%
Annualized Gain: -92.68%
Starting investment: $10,000.00
Ending investment: $1,316.00
Years: 0.94
Date Open High Low Close Volume
10/23/2015 $0.04 $0.07 $0.03 $0.07 616.70K
10/26/2015 $0.08 $0.09 $0.04 $0.08 401.40K
10/27/2015 $0.08 $0.08 $0.05 $0.05 702.20K
10/28/2015 $0.05 $0.06 $0.02 $0.03 916.40K
10/29/2015 $0.03 $0.03 $0.03 $0.03 0
ContraFect is a biotechnology company focused on discovering and developing therapeutic protein and antibody products for life-threatening, drug-resistant infectious diseases. Co. addresses drug-resistant infections using its therapeutic product candidates from its lysin and monoclonal antibody (mAb) platforms. Co.'s lysin product candidates, CF-301, is for the treatment of Staph aureus bacteremia, including endocarditis, caused by methicillin-sensitive or methicillin-resistant Staph aureus. Co.'s second product candidate is CF-404, a combination of three human mAbs for the treatment of life-threatening seasonal and pandemic varieties of influenza.
Date Close
10/23/2015$0.07
10/26/2015$0.08
10/27/2015$0.05
10/28/2015$0.03
10/29/2015$0.03
CFRXZ is categorized under the Healthcare sector; below are some other companies in the same sector:

CGEN Historical Stock Prices
CGIX Historical Stock Prices
CGNT Historical Stock Prices
CHDX Historical Stock Prices
CHE Historical Stock Prices
CHFS Historical Stock Prices
CHMA Historical Stock Prices
CHRS Historical Stock Prices
CHTP Historical Stock Prices
CIVI Historical Stock Prices

Email EnvelopeFree CFRXZ Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


CFRXZ Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.